|
2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting.
|
11678032
|
Proteomics
|
|
A database of protein expression in lung cancer.
|
11721642
|
Proteomics
|
|
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis.
|
12096119
|
Mol. Cell Proteomics
|
|
A functional annotation of subproteomes in human plasma.
|
16104058
|
Proteomics
|
|
A meeting of minds in proteomics.
|
11822353
|
Proteomics
|
|
A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
|
10728696
|
Cancer Res.
|
|
A mouse plasma peptide atlas as a resource for disease proteomics.
|
18522751
|
Genome Biol.
|
|
A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
|
18547137
|
PLoS Med.
|
|
A proteomic approach to the identification of lung cancer markers.
|
11790896
|
Dis. Markers
|
|
A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.
|
21513341
|
Anal. Chem.
|
|
A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system.
|
16047307
|
Proteomics
|
|
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.
|
14578198
|
Am. J. Pathol.
|
|
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
|
11504947
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
Application of proteomics to cancer early detection.
|
22157286
|
Cancer J
|
|
Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status.
|
10786892
|
Electrophoresis
|
|
Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study.
|
16525410
|
Nat. Biotechnol.
|
|
Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera.
|
16762624
|
Gastroenterology
|
|
Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines.
|
22110949
|
Int J Proteomics
|
|
Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments.
|
16396501
|
J. Proteome Res.
|
|
Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.
|
22367215
|
Cancer Res.
|
|
Confounding effects of hormone replacement therapy in protein biomarker studies.
|
21037107
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
|
17696519
|
J. Proteome Res.
|
|
Contributions of proteome profiling to the molecular analysis of cancer.
|
12625782
|
Technol. Cancer Res. Treat.
|
|
Discordant protein and mRNA expression in lung adenocarcinomas.
|
12096112
|
Mol. Cell Proteomics
|
|
Discovery of cancer biomarkers through the use of mouse models.
|
17320282
|
Cancer Lett.
|
|
Discovery of cancer biomarkers through the use of mouse models.
|
17320282
|
Cancer Lett.
|
|
Disease proteomics.
|
12634796
|
Nature
|
|
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
|
16117833
|
BMC Cancer
|
|
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
|
21364687
|
Nat Rev Clin Oncol
|
|
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.
|
22715141
|
Cancer Prev Res (Phila)
|
|
Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes.
|
12954092
|
In Silico Biol. (Gedrukt)
|
|
Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas.
|
12681502
|
FEBS Lett.
|
|
Gene-expression profiles predict survival of patients with lung adenocarcinoma.
|
12118244
|
Nat. Med.
|
|
Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics.
|
11943782
|
J. Biol. Chem.
|
|
Global profiling of gene expression in cancer using genomics and proteomics.
|
11804268
|
Curr. Opin. Mol. Ther.
|
|
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function.
|
12493773
|
J. Biol. Chem.
|
|
Harnessing immunity for cancer marker discovery.
|
12511908
|
Nat. Biotechnol.
|
|
Harnessing the immune response for cancer detection.
|
21454417
|
Cancer Epidemiol. Biomarkers Prev.
|
|
High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
|
17184556
|
Breast Cancer Res.
|
|
Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
|
18089831
|
Cancer Res.
|
|
Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer.
|
18769604
|
Biomark Insights
|
|
Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis.
|
11721644
|
Proteomics
|
|
Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma.
|
11051243
|
Clin. Cancer Res.
|
|
Identification of tumor-associated antigens using proteomics.
|
12625784
|
Technol. Cancer Res. Treat.
|
|
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
|
12970743
|
Oncogene
|
|
Increased throughput and reduced carryover of mass spectrometry-based proteomics using a high-efficiency nonsplit nanoflow parallel dual-column capillary HPLC system.
|
18512973
|
J. Proteome Res.
|
|
Innovative proteomic approaches for cancer biomarker discovery.
|
17907570
|
BioTechniques
|
|
Intact-protein analysis system for discovery of serum-based disease biomarkers.
|
21468941
|
Methods Mol. Biol.
|
|
Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
|
17916591
|
Mol. Cell Proteomics
|
|
Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications.
|
21372808
|
Nat Protoc
|
|
Integrating cancer genomics and proteomics in the post-genome era.
|
11788993
|
Proteomics
|
|
Integration of proteomics into systems biology of cancer.
|
22407608
|
Wiley Interdiscip Rev Syst Biol Med
|
|
Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry.
|
10740846
|
Anal. Chem.
|
|
Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.
|
18419151
|
J. Proteome Res.
|
|
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.
|
21907921
|
Cancer Cell
|
|
Making sense of microarray data to classify cancer.
|
14597962
|
Pharmacogenomics J.
|
|
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.
|
14595819
|
Proteomics
|
|
Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
|
22315094
|
Int. J. Gynecol. Cancer
|
|
Mining gene expression databases for association rules.
|
12499296
|
Bioinformatics
|
|
Mining the plasma proteome for disease applications across seven logs of protein abundance.
|
21062094
|
J. Proteome Res.
|
|
Mining the plasma proteome for cancer biomarkers.
|
18385731
|
Nature
|
|
Molecular analysis of cancer using DNA and protein microarrays.
|
12908549
|
Adv. Exp. Med. Biol.
|
|
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
|
12750293
|
Cancer Res.
|
|
Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3.
|
14595809
|
Proteomics
|
|
Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
|
17418409
|
Cancer Cell
|
|
Multi-dimensional liquid phase based separations in proteomics.
|
12659729
|
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
|
|
Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
|
18794547
|
J. Clin. Oncol.
|
|
Operomics: integrated genomic and proteomic profiling of cells and tissues.
|
15251063
|
Brief Funct Genomic Proteomic
|
|
Operomics: molecular analysis of tissues from DNA to RNA to protein.
|
11097332
|
Clin. Chem. Lab. Med.
|
|
Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.
|
12644570
|
Mol. Cell Proteomics
|
|
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
|
16104056
|
Proteomics
|
|
Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.
|
21589862
|
PLoS ONE
|
|
Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.
|
18311905
|
J. Proteome Res.
|
|
Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.
|
12844362
|
Genome Biol.
|
|
Profiling of the cell surface proteome.
|
14625857
|
Proteomics
|
|
Protein based microarrays: a tool for probing the proteome of cancer cells and tissues.
|
11721639
|
Proteomics
|
|
Protein profiles associated with survival in lung adenocarcinoma.
|
14573703
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.
|
12192603
|
Neoplasia
|
|
Proteomic analysis of eIF-5A in lung adenocarcinomas.
|
12687616
|
Proteomics
|
|
Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
|
12114434
|
Clin. Cancer Res.
|
|
Proteomic approaches for cancer biomarker discovery in plasma.
|
17941811
|
Expert Rev Proteomics
|
|
Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.
|
11708463
|
Ann. N. Y. Acad. Sci.
|
|
Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer.
|
12882525
|
J Mammary Gland Biol Neoplasia
|
|
Proteomics in early detection of cancer.
|
11568117
|
Clin. Chem.
|
|
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
|
11691811
|
Cancer Res.
|
|
Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
|
11705844
|
Clin. Cancer Res.
|
|
Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS.
|
16889424
|
J. Proteome Res.
|
|
RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
|
12473593
|
Clin. Cancer Res.
|
|
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
|
21987723
|
Cancer Res.
|
|
The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas.
|
11280781
|
Cancer Res.
|
|
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
|
12234996
|
Cancer Res.
|
|
The Human Proteome Organization: a mission to advance proteome knowledge.
|
12169681
|
Mol. Cell Proteomics
|
|
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes.
|
11278880
|
J. Biol. Chem.
|
|
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18.
|
12242154
|
Cancer Cell
|
|
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.
|
21653680
|
Cancer Res.
|
|
Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line.
|
11675018
|
Gene
|
|
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
|
17200335
|
Clin. Cancer Res.
|
|
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
|
17200335
|
Clin. Cancer Res.
|
|
Unraveling the complex proteome for biomarker discovery in gastrointestinal and liver diseases.
|
17064703
|
Gastroenterology
|
|
Virtual genome scan: a tool for restriction landmark-based scanning of the human genome.
|
11483587
|
Genome Res.
|
